Search

Your search keyword '"Timothy J Vyse"' showing total 291 results

Search Constraints

Start Over You searched for: Author "Timothy J Vyse" Remove constraint Author: "Timothy J Vyse"
291 results on '"Timothy J Vyse"'

Search Results

1. Age acquired skewed X chromosome inactivation is associated with adverse health outcomes in humans

2. COVID-19 and systemic lupus erythematosus genetics: A balance between autoimmune disease risk and protection against infection.

3. Profiling RNA-Seq at multiple resolutions markedly increases the number of causal eQTLs in autoimmune disease.

4. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.

5. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.

6. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production.

7. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus.

8. Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression.

9. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap.

10. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus.

11. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.

12. Large scale replication study of the association between HLA class II/BTNL2 variants and osteoarthritis of the knee in European-descent populations.

13. Determination of the loss of function complement C4 exon 29 CT insertion using a novel paralog-specific assay in healthy UK and Spanish populations.

14. A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation.

15. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

16. Identification of MAMDC1 as a candidate susceptibility gene for systemic lupus erythematosus (SLE).

17. Defining the role of the MHC in autoimmunity: a review and pooled analysis.

18. Common variants within MECP2 confer risk of systemic lupus erythematosus.

19. Identification of two independent risk factors for lupus within the MHC in United Kingdom families.

20. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice.

21. 1401 A Genome Wide Association Scan of SLE genetic risk in a cohort of African-American persons

24. Genetics of SLE: does this explain susceptibility and severity across racial groups?

25. Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with

26. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

27. OA13 Comprehensive genetic and functional analyses of Fc gamma receptors explain response to rituximab therapy for autoimmune rheumatic diseases

28. Th1 responses in vivo require cell-specific provision of OX40L dictated by environmental cues

29. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity

30. Comprehensive genetic and functional analysis of FcγRs in rituximab therapy for autoimmunity reveals a key role for FcγRIIIa on NK cells

31. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups

32. Contributors

33. Major histocompatibility complex and SLE

34. Trans-Ancestral Fine-Mapping and Epigenetic Annotation as Tools to Delineate Functionally Relevant Risk Alleles at

35. Independent Replication on Genome-Wide Association Study Signals Identifies IRF3 as a Novel Locus for Systemic Lupus Erythematosus

36. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity that may underly population disparities in this disease

37. Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity

38. Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans

39. Meta-analysis of GWAS on both Chinese and European populations identifies GPR173 as a novel X chromosome susceptibility gene for SLE

40. Identification of ST3AGL4, MFHAS1, CSNK2A2 and CD226 as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning

41. Multiple signals at the extended 8p23 locus are associated with susceptibility to systemic lupus erythematosus

42. THU0018 GENETIC FACTORS AND RESPONSE TO RITUXIMAB THERAPY IN SLE

43. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

44. Complement component 4 genes contribute sex-specific vulnerability in diverse illnesses

45. 240 Trans-ancestral exclusion mapping strategy prioritises risk alleles at IKZF3 with increased biological relevance

46. Systemic Lupus Erythematosus

47. Nucleolin acts as the receptor for C1QTNF4 and supports C1QTNF4-mediated innate immunity modulation

48. Tartrate‐Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus

49. Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture

50. Trans-Ancestral Fine-Mapping and Epigenetic Annotation as Tools to Delineate Functionally Relevant Risk Alleles at IKZF1 and IKZF3 in Systemic Lupus Erythematosus

Catalog

Books, media, physical & digital resources